Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantation

Transplant Proc. 1999 Feb-Mar;31(1-2):80-1. doi: 10.1016/s0041-1345(98)01446-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Alprostadil / administration & dosage
  • Alprostadil / therapeutic use*
  • Cardiotonic Agents / therapeutic use
  • Dobutamine / therapeutic use
  • Drug Administration Schedule
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Graft Rejection / epidemiology
  • Heart Transplantation / mortality
  • Heart Transplantation / physiology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Morbidity
  • Postoperative Complications / epidemiology
  • Retrospective Studies
  • Survival Analysis
  • Time Factors

Substances

  • Cardiotonic Agents
  • Fibrinolytic Agents
  • Immunosuppressive Agents
  • Dobutamine
  • Alprostadil